US EditionPublished • loading... • Updated
Antibiotice Iași makes strategic shift in exports to European markets
Summary by Business Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Antibiotice Iași makes strategic shift in exports to European markets
Antibiotice Iași, the only drug manufacturer controlled by the Romanian state, reported a turnover of 645.28 million RON for the year 2025, a decrease of 29.7 million RON compared to the previous fiscal year. The result reflects a context marked by economic uncertainty and structural changes in international markets, particularly in the United States, where […] The post Antibiotice Iași makes strategic shift in exports to European markets appear…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
